Uresta

Uresta is a company focused on innovative bladder support solutions for women, specializing in products designed to prevent urinary leakage during various activities. Uresta provides effective bladder support solutions for women experiencing leakage. Founded in 2003 in Moncton, Canada, the company raised USD 3. 000 mn in March 2025 from BDC Capital, bringing the total amount raised to USD 3.

000 mn. Founded by individuals dedicated to addressing women's health needs, Uresta has established its presence in North America, particularly in the United States and Canada. Uresta® specializes in innovative bladder support solutions specifically designed for women experiencing bladder leakage. The company’s flagship product is the Uresta device, a vaginal insert that provides support to the pelvic floor muscles through the vaginal wall, effectively preventing leaks during activities that exert pressure on the bladder, such as sneezing, laughing, or exercising.

This product allows users to maintain normal urinary function while offering substantial protection from leaks, addressing a common issue that affects women as they age. The Uresta device was developed after more than 20 years of research and is aimed at a diverse customer base that includes women of various ages who face light to severe bladder leakage. Uresta products are marketed and sold primarily in North America, with specific emphasis on reaching consumers in the United States and Canada. Uresta operates a direct-to-consumer sales model, with product transactions occurring primarily through its online platform.

The company’s primary revenue stream is derived from the sale of the Uresta Starter Kit, which includes three commonly used sizes of the device, priced at USD 179. Customers can also request additional sizes free of charge within a 30-day period if the initial sizes do not meet their needs. The company emphasizes a risk-free purchase environment, offering a 30-day refund policy for the Starter Kit and free shipping on orders exceeding USD 50. Uresta’s business structure is complemented by support systems, including marketing efforts through social media and direct engagement with health professionals, which reinforces the product's credibility and encourages recommendations within the healthcare community.

In March 2025, Uresta raised USD 3. 000 mn in venture funding from new investor BDC Capital, which will be used to support the launch of its product. The company aims to expand its product offerings and enter new markets within North America, focusing on increasing its customer base in both the United States and Canada. Upcoming product designs are currently under development, with an emphasis on enhancing the user experience and addressing specific consumer needs.